Abstract | OBJECTIVES: DESIGN AND METHODS: We prospectively analyzed 61 patients. The diagnosis of ischemic AHF was confirmed by coronary angiography or stress myocardial perfusion imaging. Plasma levels of BNP were measured at admission (BNP1) and 48 h after admission (BNP2). RESULTS: The mean age of the study patients was 67 years. In these patients, 70.5% had diabetes and 47.5% had dialysis-dependent CKD; 28 of these patients (45.9%) had an ischemic etiology with significantly higher concentrations of BNP1 and BNP2 than did patients without ischemia. The area under the receiver operating characteristic curve was 0.755 (P=0.001) for BNP1 and 0.868 (P<0.001) for BNP2 to detect ischemic etiology of AHF. Plasma BNP1 >2907 ng/L (odds ratio [OR], 10.9; 95% confidence interval [CI] 2.5-48.4; P=0.002) and BNP2 >2322 ng/L (OR 93.1, 95% CI 7.0-1238.7; P=0.001) were independently associated with an ischemic etiology of AHF. CONCLUSIONS: Plasma BNP may represent a clinically useful non-invasive tool for identification of ischemic etiology of AHF in patients with stage 4-5 CKD.
|
Authors | Sung Eun Kim, Sunghoon Park, Jwa-Kyung Kim, Sung Gyun Kim, Hyung Jik Kim, Young Rim Song |
Journal | Clinical biochemistry
(Clin Biochem)
Vol. 47
Issue 6
Pg. 344-8
(Apr 2014)
ISSN: 1873-2933 [Electronic] United States |
PMID | 24486650
(Publication Type: Journal Article, Observational Study, Research Support, Non-U.S. Gov't)
|
Copyright | Copyright © 2014 The Canadian Society of Clinical Chemists. Published by Elsevier Inc. All rights reserved. |
Chemical References |
- Natriuretic Peptide, Brain
|
Topics |
- Aged
- Female
- Heart Failure
(blood, diagnostic imaging, etiology)
- Hospitalization
- Humans
- Male
- Myocardial Ischemia
(blood, complications, diagnostic imaging)
- Natriuretic Peptide, Brain
(blood)
- ROC Curve
- Renal Insufficiency, Chronic
(blood, complications)
- Risk Factors
- Ultrasonography
|